|
|||||
|
Back | Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 30 | Option Exercise | 0.00 | 5,206 | 0 | 41,608 | Apr 30 06:33 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 30 | Sale | 12.04 | 2,007 | 24,169 | 39,601 | Apr 30 06:33 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 30 | Option Exercise | 0.00 | 5,207 | 0 | 38,736 | Jan 30 06:52 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 30 | Sale | 7.99 | 2,334 | 18,649 | 36,402 | Jan 30 06:52 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 30 | Option Exercise | 0.00 | 5,207 | 0 | 35,162 | Nov 01 04:40 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 31 | Sale | 5.20 | 1,633 | 8,487 | 33,529 | Nov 01 04:40 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jul 30 | Option Exercise | 0.00 | 5,207 | 0 | 31,839 | Aug 01 04:26 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jul 31 | Sale | 9.65 | 1,884 | 18,189 | 29,955 | Aug 01 04:26 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 30 | Option Exercise | 0.00 | 3,206 | 0 | 27,768 | May 02 04:31 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | May 01 | Sale | 9.88 | 1,136 | 11,219 | 26,632 | May 02 04:31 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 30 | Option Exercise | 0.00 | 3,207 | 0 | 24,421 | Feb 01 04:15 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 30 | Sale | 11.78 | 1,412 | 16,633 | 23,009 | Feb 01 04:15 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 30 | Option Exercise | 0.00 | 3,207 | 0 | 22,379 | Nov 01 07:33 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 31 | Sale | 12.88 | 1,165 | 15,006 | 21,214 | Nov 01 07:33 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jul 30 | Option Exercise | 0.00 | 3,207 | 0 | 20,358 | Aug 02 05:45 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Aug 01 | Sale | 15.67 | 1,186 | 18,585 | 19,172 | Aug 02 05:45 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 30 | Option Exercise | 0.00 | 3,206 | 0 | 18,249 | May 03 07:05 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | May 02 | Sale | 11.75 | 1,098 | 12,902 | 17,151 | May 03 07:05 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 03 | Option Exercise | 9.06 | 1,828 | 16,570 | 16,025 | Jan 04 04:19 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jan 03 | Sale | 28.96 | 1,828 | 52,939 | 14,197 | Jan 04 04:19 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Dec 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,597 | Dec 02 05:43 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Dec 01 | Sale | 29.13 | 400 | 11,652 | 14,197 | Dec 02 05:43 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Nov 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,597 | Nov 02 05:28 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Nov 01 | Sale | 33.24 | 400 | 13,296 | 14,197 | Nov 02 05:28 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 27 | Option Exercise | 7.26 | 400 | 2,904 | 14,597 | Oct 28 07:23 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 27 | Sale | 35.00 | 400 | 14,000 | 14,197 | Oct 28 07:23 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,597 | Oct 04 05:16 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Oct 01 | Sale | 29.92 | 400 | 11,968 | 14,197 | Oct 04 05:16 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Sep 07 | Option Exercise | 7.26 | 1,600 | 11,616 | 15,797 | Sep 08 05:08 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Sep 07 | Sale | 35.00 | 1,600 | 56,000 | 14,197 | Sep 08 05:08 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Sep 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,597 | Sep 02 04:22 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Sep 01 | Sale | 32.34 | 400 | 12,936 | 14,197 | Sep 02 04:22 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Aug 02 | Option Exercise | 7.26 | 400 | 2,904 | 14,204 | Aug 03 05:39 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Aug 02 | Sale | 31.21 | 400 | 12,484 | 13,804 | Aug 03 05:39 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jun 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,204 | Jun 02 04:49 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Jun 01 | Sale | 27.74 | 400 | 11,096 | 13,804 | Jun 02 04:49 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | May 03 | Option Exercise | 7.26 | 800 | 5,808 | 14,604 | May 04 04:27 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | May 03 | Sale | 34.99 | 800 | 27,996 | 13,804 | May 04 04:27 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 05 | Option Exercise | 7.26 | 400 | 2,904 | 14,204 | Apr 06 04:04 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 05 | Sale | 35.00 | 400 | 14,000 | 13,804 | Apr 06 04:04 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 01 | Option Exercise | 7.26 | 400 | 2,904 | 14,204 | Apr 02 05:22 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Apr 01 | Sale | 31.55 | 400 | 12,620 | 13,804 | Apr 02 05:22 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Mar 16 | Option Exercise | 7.26 | 800 | 5,808 | 14,604 | Mar 16 06:50 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Mar 16 | Sale | 45.00 | 800 | 36,000 | 13,804 | Mar 16 06:50 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Mar 01 | Option Exercise | 7.26 | 800 | 5,808 | 14,604 | Mar 02 05:29 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Mar 01 | Sale | 35.95 | 800 | 28,760 | 13,804 | Mar 02 05:29 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Feb 18 | Option Exercise | 7.26 | 800 | 5,808 | 12,800 | Feb 22 04:07 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Feb 18 | Sale | 36.27 | 800 | 29,018 | 12,000 | Feb 22 04:07 PM |
NRIX | Hansen Gwenn | Chief Scientific Officer | Nov 30 | Option Exercise | 0.84 | 12,000 | 10,080 | 12,000 | Dec 01 09:32 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite